PHARMACYTE BIOTECH, INC. Earnings Per Share (Basic)
PHARMACYTE BIOTECH, INC. (PMCB) reported Earnings Per Share (Basic) of -$0.54 per share for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-14
- PHARMACYTE BIOTECH, INC. earnings per share, basic for the quarter ending 2026-07-31 was -$0.54.
- PHARMACYTE BIOTECH, INC. earnings per share, basic for the quarter ending 2026-04-30 was -$0.46, a 135.70% decline year-over-year.
- PHARMACYTE BIOTECH, INC. earnings per share, basic for the quarter ending 2026-01-31 was -$0.17.
- PHARMACYTE BIOTECH, INC. earnings per share, basic for the quarter ending 2025-10-31 was -$1.24.
- PHARMACYTE BIOTECH, INC. earnings per share, basic for fiscal 2026 was -$2.77, a 186.83% decline from fiscal 2025.
- PHARMACYTE BIOTECH, INC. earnings per share, basic for fiscal 2025 was $3.19.
- PHARMACYTE BIOTECH, INC. earnings per share, basic for fiscal 2024 was -$1.80.
- PHARMACYTE BIOTECH, INC. earnings per share, basic for fiscal 2023 was -$0.22.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | -$0.54 10-Q · filed 2026-09-14 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-09-14 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-09-14 | -$2.20 derived: net income ÷ weighted average shares · filed 2026-09-14 | |||
| 2026-04-30 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$1.67 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$2.77 10-K · filed 2026-07-29 | |||
| 2026-01-31 | -$0.17 10-Q · filed 2026-03-17 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-03-17 | -$2.41 10-Q · filed 2026-03-17 | -$1.29 derived: net income ÷ weighted average shares · filed 2026-09-14 | |||
| 2025-10-31 | -$1.24 10-Q · filed 2025-12-18 | -$2.47 10-Q · filed 2025-12-18 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-09-14 | -$1.61 derived: net income ÷ weighted average shares · filed 2026-09-14 | |||
| 2025-07-31 | -$1.23 10-Q · filed 2026-09-14 | $0.06 derived: net income ÷ weighted average shares · filed 2026-09-14 | -$0.38 derived: net income ÷ weighted average shares · filed 2026-09-14 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-09-14 | |||
| 2025-04-30 | $1.28 derived: net income ÷ weighted average shares · filed 2026-07-29 | $0.83 derived: net income ÷ weighted average shares · filed 2026-07-29 | $0.39 derived: net income ÷ weighted average shares · filed 2026-07-29 | $3.19 10-K · filed 2026-07-29 | |||
| 2025-01-31 | -$0.44 10-Q · filed 2026-03-17 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-03-17 | $1.67 10-Q · filed 2026-03-17 | $1.56 derived: net income ÷ weighted average shares · filed 2026-03-17 | |||
| 2024-10-31 | -$0.39 10-Q · filed 2025-12-18 | $1.83 10-Q · filed 2025-12-18 | $1.90 derived: net income ÷ weighted average shares · filed 2025-12-18 | $1.17 derived: net income ÷ weighted average shares · filed 2025-12-18 | |||
| 2024-07-31 | $1.90 10-Q · filed 2025-09-15 | $2.23 derived: net income ÷ weighted average shares · filed 2025-09-15 | $1.50 derived: net income ÷ weighted average shares · filed 2025-09-15 | $1.21 derived: net income ÷ weighted average shares · filed 2025-09-15 | |||
| 2024-04-30 | -$0.30 derived: net income ÷ weighted average shares · filed 2025-08-11 | -$0.96 derived: net income ÷ weighted average shares · filed 2025-08-11 | -$1.22 derived: net income ÷ weighted average shares · filed 2025-08-11 | -$1.80 10-K · filed 2025-08-11 | |||
| 2024-01-31 | -$0.65 10-Q · filed 2025-03-17 | -$0.91 derived: net income ÷ weighted average shares · filed 2025-03-17 | -$1.47 10-Q · filed 2025-03-17 | -$1.24 derived: net income ÷ weighted average shares · filed 2025-03-17 | |||
| 2023-10-31 | -$0.26 10-Q · filed 2024-12-13 | -$0.85 10-Q · filed 2024-12-13 | -$0.70 derived: net income ÷ weighted average shares · filed 2024-12-13 | -$0.68 derived: net income ÷ weighted average shares · filed 2024-12-13 | |||
| 2023-07-31 | -$0.54 10-Q · filed 2024-09-17 | -$0.28 10-Q · filed 2023-09-18 | -$0.45 derived: net income ÷ weighted average shares · filed 2024-09-17 | -$0.47 derived: net income ÷ weighted average shares · filed 2024-09-17 | -$0.55 derived: net income ÷ weighted average shares · filed 2024-09-17 | ||
| 2023-04-30 | -$0.01 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$0.05 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$0.22 10-K · filed 2024-08-13 | |||
| 2023-01-31 | -$0.04 10-Q · filed 2024-03-18 | -$0.13 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$0.21 10-Q · filed 2024-03-18 | ||||
| 2022-10-31 | -$0.09 10-Q · filed 2023-12-15 | -$0.17 10-Q · filed 2023-12-15 | |||||
| 2022-07-31 | -$0.07 10-Q · filed 2023-09-18 | ||||||
| 2022-04-30 | -$0.27 10-K · filed 2023-07-31 | ||||||
| 2022-01-31 | -$0.04 10-Q · filed 2023-03-16 | -$0.21 10-Q · filed 2023-03-16 | |||||
| 2021-10-31 | -$0.06 10-Q · filed 2022-12-14 | -$0.21 10-Q · filed 2022-12-14 | |||||
| 2021-07-31 | -$0.64 10-Q · filed 2022-09-14 | ||||||
| 2021-04-30 | -$2.45 10-K · filed 2022-07-28 | ||||||
| 2015-01-31 | $0.00 10-Q · filed 2015-03-13 | -$0.01 10-Q · filed 2015-03-13 | |||||
| 2014-10-31 | -$0.01 10-Q · filed 2014-12-15 | -$0.01 10-Q · filed 2014-12-15 | |||||
| 2014-07-31 | $0.00 10-Q · filed 2014-09-15 | ||||||
| 2014-04-30 | -$0.05 10-K · filed 2014-08-04 | ||||||
| 2014-01-31 | $0.00 10-Q · filed 2015-03-13 | -$0.02 10-Q · filed 2015-03-13 | |||||
| 2013-10-31 | -$0.01 10-Q · filed 2014-12-15 | -$0.02 10-Q · filed 2014-12-15 | |||||
| 2013-07-31 | -$0.01 10-Q · filed 2014-09-15 | ||||||
| 2013-04-30 | $0.00 10-K · filed 2014-08-04 | ||||||
| 2013-01-31 | $0.00 10-Q · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | |||||
| 2012-10-31 | $0.00 10-Q · filed 2013-12-16 | $0.00 10-Q · filed 2013-12-16 | |||||
| 2012-07-31 | $0.00 10-Q · filed 2013-09-16 | ||||||
| 2012-04-30 | -$0.01 10-K · filed 2013-07-29 | $0.01 10-K · filed 2012-08-14 | |||||
| 2012-01-31 | $0.00 10-Q · filed 2013-03-26 | $0.00 10-Q · filed 2013-03-26 | -$0.01 10-Q · filed 2012-03-21 | ||||
| 2011-10-31 | $0.00 10-Q · filed 2012-12-26 | $0.00 10-Q · filed 2012-12-26 | |||||
| 2011-07-31 | $0.00 10-Q · filed 2012-09-19 | ||||||
| 2011-04-30 | $0.00 10-K · filed 2012-08-14 | ||||||
| 2011-01-31 | $0.00 10-Q · filed 2012-03-21 | $0.00 10-Q · filed 2012-03-21 | |||||
| 2010-10-31 | $0.00 10-Q · filed 2011-12-15 | $0.00 10-Q · filed 2011-12-15 | |||||
| 2010-07-31 | $0.00 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |